See What HealthDay Can Do For You
Contact Us

Single-Dose Antibiotics Effective for Surgery Infection

One-time treatment before surgery has rates similar to 24-hour dose for preventing surgical site infection

TUESDAY, Nov. 21 (HealthDay News) -- The risk of surgical site infection can be reduced just as effectively with a single dose of antibiotics prior to surgery as with a 24-hour dosing regimen, according to a study in the November issue of the Archives of Surgery.

Silvia Nunes Szente Fonseca, M.D., M.P.H., of Hospital Sao Francisco in Sao Paulo, Brazil, and colleagues conducted a study of 6,140 surgical patients treated from February to October 2002 with a 24-hour prophylactic dose of antibiotics and 6,159 patients treated between December 2002 and August 2003 with a single-dose antibiotic prophylaxis.

In all, 12,299 patients were followed-up during their hospital stay. Both regimens produced similar rates of surgical site infection -- 2 percent for the 24-hour regimen group and 2.1 percent for the single-dose group -- but the number of vials of cephazolin used decreased from 1,259 a month to 467, saving the hospital $1,980 a month. There was 99 percent compliance with the single-dose regimen.

"One-dose prophylaxis is feasible," the authors conclude. "In this era of restricted hospital budgets and increased bacterial resistance, one-dose prophylaxis may provide a way to improve performance by lowering costs."

An accompanying editorial states that "the most impressive aspect of this research is the successful implementation of a hospital-wide process change, which overnight standardized antibiotic administration for every operation in every specialty."

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.